FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154657415> ?p ?o ?g. }

• W3154657415 endingPage "1843" @default.
• W3154657415 startingPage "1838" @default.
• W3154657415 abstract "Atopic dermatitis (AD) is a common chronic inflammatory condition. Ustekinumab is a human monoclonal antibody approved for psoriasis, that targets the interleukin (IL)-12 and IL-23, and it may also play a role in AD. Administration of ustekinumab in AD is presented in anecdotal reports with conflicting results. Our aim was to evaluate the precise value of ustekinumab on AD.We systematically reviewed published data involving AD treated with ustekinumab. The main outcome was clinical improvement. We classified this in three categories: 'complete response,' 'partial response,' and 'no response.' A multivariant model was used to assess the effectiveness and the following potential predictive factors: gender, age, duration of AD, asthma, previous use of biologics, previous systemic therapies,levels of IgE and duration of ustekinumab therapy.Data on 23 patients were analyzed. Complete AD remission was reported in 8 patients (34.8%), while the absence of response was observed also in 8 patients (34.8%). Partial response was reported in 7 patients (30.4%). No differences were observed with the predictive factors.The IL-12/23 pathway is likely not an attractive target for AD. Other effective treatments are available and should be prioritized with a good safety profile. WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?Administration of ustekinumab in AD (atopic dermatitis) has been presented in anecdotical reports with conflicting results.WHAT DOES THIS STUDY ADD?This work presents the largest cohort of AD patients treated with ustekinumab in a real-world setting.Ustekinumab resulted in similar rates of complete, partial, and negative responses.Our findings demonstrate the IL-12/23 pathway is not an attractive target in AD.More novel and effective treatments for AD are available and should be prioritized.The impact of anti-IL-12/IL-23p40 therapy in AD is still unclarified due to limited controlled trials." @default.
• W3154657415 created "2021-04-26" @default.
• W3154657415 creator A5040541115 @default.
• W3154657415 creator A5056447112 @default.
• W3154657415 date "2021-08-25" @default.
• W3154657415 modified "2023-09-26" @default.
• W3154657415 title "Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence" @default.
• W3154657415 cites W1488585496 @default.
• W3154657415 cites W1571891468 @default.
• W3154657415 cites W1978768695 @default.
• W3154657415 cites W1980040943 @default.
• W3154657415 cites W1990856706 @default.
• W3154657415 cites W1995108121 @default.
• W3154657415 cites W2002600662 @default.
• W3154657415 cites W2003774999 @default.
• W3154657415 cites W2016850513 @default.
• W3154657415 cites W2040342875 @default.
• W3154657415 cites W2040922008 @default.
• W3154657415 cites W2043082699 @default.
• W3154657415 cites W2043793146 @default.
• W3154657415 cites W2045189254 @default.
• W3154657415 cites W2053058303 @default.
• W3154657415 cites W2057940993 @default.
• W3154657415 cites W2079494090 @default.
• W3154657415 cites W2080191428 @default.
• W3154657415 cites W2080998405 @default.
• W3154657415 cites W2093066805 @default.
• W3154657415 cites W2118630839 @default.
• W3154657415 cites W2155331534 @default.
• W3154657415 cites W2156992552 @default.
• W3154657415 cites W2158799320 @default.
• W3154657415 cites W2162201817 @default.
• W3154657415 cites W2196998502 @default.
• W3154657415 cites W2338839574 @default.
• W3154657415 cites W2432916178 @default.
• W3154657415 cites W2524051065 @default.
• W3154657415 cites W2530971708 @default.
• W3154657415 cites W2562650315 @default.
• W3154657415 cites W2593200577 @default.
• W3154657415 cites W2601555940 @default.
• W3154657415 cites W2611526721 @default.
• W3154657415 cites W2750544646 @default.
• W3154657415 cites W2765823142 @default.
• W3154657415 cites W2792691154 @default.
• W3154657415 cites W2907756900 @default.
• W3154657415 cites W2952535698 @default.
• W3154657415 cites W2955427335 @default.
• W3154657415 cites W4211026773 @default.
• W3154657415 cites W4230355606 @default.
• W3154657415 doi "https://doi.org/10.1080/09546634.2021.1914315" @default.
• W3154657415 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33849369" @default.
• W3154657415 hasPublicationYear "2021" @default.
• W3154657415 type Work @default.
• W3154657415 sameAs 3154657415 @default.
• W3154657415 citedByCount "6" @default.
• W3154657415 countsByYear W31546574152021 @default.
• W3154657415 countsByYear W31546574152022 @default.
• W3154657415 countsByYear W31546574152023 @default.
• W3154657415 crossrefType "journal-article" @default.
• W3154657415 hasAuthorship W3154657415A5040541115 @default.
• W3154657415 hasAuthorship W3154657415A5056447112 @default.
• W3154657415 hasConcept C126322002 @default.
• W3154657415 hasConcept C16005928 @default.
• W3154657415 hasConcept C203014093 @default.
• W3154657415 hasConcept C2777138892 @default.
• W3154657415 hasConcept C2778329239 @default.
• W3154657415 hasConcept C2778975655 @default.
• W3154657415 hasConcept C2779134260 @default.
• W3154657415 hasConcept C2780564577 @default.
• W3154657415 hasConcept C71924100 @default.
• W3154657415 hasConceptScore W3154657415C126322002 @default.
• W3154657415 hasConceptScore W3154657415C16005928 @default.
• W3154657415 hasConceptScore W3154657415C203014093 @default.
• W3154657415 hasConceptScore W3154657415C2777138892 @default.
• W3154657415 hasConceptScore W3154657415C2778329239 @default.
• W3154657415 hasConceptScore W3154657415C2778975655 @default.
• W3154657415 hasConceptScore W3154657415C2779134260 @default.
• W3154657415 hasConceptScore W3154657415C2780564577 @default.
• W3154657415 hasConceptScore W3154657415C71924100 @default.
• W3154657415 hasIssue "4" @default.
• W3154657415 hasLocation W31546574151 @default.
• W3154657415 hasLocation W31546574152 @default.
• W3154657415 hasOpenAccess W3154657415 @default.
• W3154657415 hasPrimaryLocation W31546574151 @default.
• W3154657415 hasRelatedWork W1595653575 @default.
• W3154657415 hasRelatedWork W1995046720 @default.
• W3154657415 hasRelatedWork W2288445425 @default.
• W3154657415 hasRelatedWork W2766755230 @default.
• W3154657415 hasRelatedWork W2803266532 @default.
• W3154657415 hasRelatedWork W2947172646 @default.
• W3154657415 hasRelatedWork W3041310696 @default.
• W3154657415 hasRelatedWork W3138584436 @default.
• W3154657415 hasRelatedWork W4361798956 @default.
• W3154657415 hasRelatedWork W71416396 @default.
• W3154657415 hasVolume "33" @default.
• W3154657415 isParatext "false" @default.
• W3154657415 isRetracted "false" @default.
• W3154657415 magId "3154657415" @default.

• next